Nasdaq GlobeNewswire

Startup Qwyk enables Logistics providers to create their own Online Shipping Schedules

Del

ROTTERDAM, The Netherlands, May 08, 2018 (GLOBE NEWSWIRE) -- Logistics tech startup Qwyk announced the public launch of their QwykSchedules(TM) product. Qwyk's products are designed to transform the way logistics companies interact with their customers.

QwykSchedules is a new product that aims to offer a digital solution for logistics companies who want to publish and market their services online. With QwykSchedules, subscribing companies can construct their own departure schedules by setting up routing rules.  They can either host it in the cloud through a fully customizable page on the Qwyk platform or integrate it into their site and TMS through APIs (Application Programming Interfaces or Web services.) Promising extremely low maintenance, Qwyk's engine uses the routing rules to compile subscriber's schedules once a customer searches and provides real-time data based on what their assigned providers offer.

"Having been involved in the logistics industry for over 10 years, both on the Business side and Technology side, I have seen first-hand the challenges companies face. One challenge specifically is in getting the often tens of thousands of services offered to be visible in a searchable way," says Founder Martyn Verhaegen. "With the advent of the Digital Freight Forwarder, who have marketed themselves as an alternative on the premise that they can provide the visibility BCO's and other parties are looking for, that their 'traditional' counterparts cannot. It is becoming increasingly important for logistics companies to fill these visibility gaps."

"Together with rates and tracking data, we believe, services guide and schedule information form the cornerstones of supply chain visibility," the Netherlands based innovator adds. "With QwykSchedules, we aim to offer logistics industry parties a low-maintenance, affordable, and reliable way to get their services and schedules online and searchable by their customers within hours."

The online product, which has been in use by a number of subscribers, provides an easy-to-use interface in which subscribers can pick the Air, Ocean FCL and LCL providers they need and link them to a powerful routing guide which constructs end-to-end and multimodal trade lanes. Shippers and other parties can then use the subscriber's dedicated front-end page to conveniently search through their schedules.

"The potential for QwykSchedules lies in the fact that this is a product that provides an output immediately consumable by subscriber's customers. Traditional sailing schedule feeds generally leave it to their customers to transform the data they provide into something that is relevant and presentable while ingesting a lot of waste-data in the process. Along with the feeds, we also provide the software to do that transformation and immediately serve solutions to customers," Martyn Verhaegen explains.

"Our objective is to have new subscribers set up with their schedules in hours, not days or weeks, handling use-cases from simple port-to-port services to complex multi-leg point-to-point moves, including configurable pre- and on-carriage schedules, across all modalities. End-to-end services are the industry's end-game and the solution can scale to fit companies of any size, from local forwarders and NVO's to global enterprises."

About

Qwyk launched in early 2017 and was founded on the belief in automating and re-using existing data through intelligent transformations, to achieve related objectives and visibility and minimize costly human maintenance efforts. Qwyk's products are able to be tailored to your branding and marketing requirements at moment's notice. Meaning, although your customers may be using Qwyk's technology, to them it will still feel like it is entirely yours.

Contact Information

Website
www.qwyk.io

Business enquiries
get.started@qwyk.io

Press
press@qwyk.io




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Qwyk - B.V. via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

Bombardier Will Fully Cooperate with the AMF Review16.11.2018 00:06Pressemelding

MONTRÉAL, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Bombardier acknowledges the announcement by the Autorité des marchés financiers (AMF) that it is reviewing the operations surrounding the establishment by Bombardier of an Automatic Securities Disposition Plan (ASDP) in August 2018 and various subsequent announcements. The ASDP had been reviewed by the AMF prior to its establishment on August 15, 2018. Bombardier intends to fully cooperate with the AMF in its review. The Company has taken the necessary measures to suspend all sales of securities pursuant to the ASDP until further notice. About Bombardier With over 69,500 employees across four business segments, Bombardier is a global leader in the transportation industry, creating innovative and game-changing planes and trains. Our products and services provide world-class transportation experiences that set new standards in passenger comfort, energy efficiency, reliability and safety. Headquartered in Montreal, Canada, Bombardier has product

ERYTECH Partners with New York Blood Center for Red Blood Cell Supply and Research15.11.2018 22:05Pressemelding

LYON, France and CAMBRIDGE, Mass., Nov. 15, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances inside red blood cells, today announced a strategic partnership with New York Blood Center (NYBC) for red blood cell supply and research. The partnership encompasses NYBC becoming a long-term supplier of donor red blood cells (RBC) to ERYTECH, enabling ERYTECH to diversify and broaden its supply of RBC source materials for the production of eryaspase and future product candidates derived from its proprietary ERYCAPS® platform as the company ramps up clinical development. Specifically for the Phase 3 trial in second-line metastatic pancreatic cancer that recently started enrolling patients in Europe, and the Phase 2 trial in first-line triple negative breast cancer (TNBC), which are both expected to begin enrollment in the United States early in 2019. The partnershi

Zageno Deepens Engagement with Scientists and Vendors through Its Meaningful and Unbiased Rating System for Scientific Products — Scientific Score gets Algorithm Update15.11.2018 15:37Pressemelding

Call for Contributions: Zageno’s rating system for scientific products — the Scientific Score — adds a crucial dimension to help research scientists purchase the right material for their experiment. Scientists: share your experimental data and professional experience about products; Life Science Vendors: provide additional product-specific resources and data points to make your products reach the right scientist CAMBRIDGE, Mass. USA and BERLIN, Germany, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Zageno Inc., the largest and fastest-growing online marketplace for research materials, today issues an open call for scientists and vendors alike to contribute to the continuous improvement of the Scientific Score. Designed as an unbiased indicator to help purchasing scientists navigate the enormous amount of product information, the Scientific Score is the result of proprietary algorithms calculating and weighing different data points across multiple information formats. Among others, factors like rec

Motiv Ring Expands International Footprint and Delivers Industry-First Sizing Process15.11.2018 15:00Pressemelding

The wearable ring lands in 20 new countries and eight new stores, and introduces frictionless sizing method SAN FRANCISCO, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Motiv Inc., creators of breakthrough wearable technology, today announced an increase of its product availability through new international availability and a new digital sizing set alternative. Motiv Ring’s international expansion will be through its website MyMotiv.com. Featured countries include: North America (Canada), Europe (Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Hungary, Italy, Lithuania, Latvia, Netherlands, Poland, Portugal, Spain, Sweden, United Kingdom, Norway and Switzerland), as well as Japan, Taiwan, Turkey, Australia and New Zealand. Good fit is imperative to great functionality. To date, Motiv Ring users select their sizes after receiving a physical sizing kit in the mail. Releasing in Open Beta , Motiv Ring users will now have the additional option of determining their Motiv size via a

SignalFx Delivers Next Generation of Application Performance Monitoring15.11.2018 15:00Pressemelding

The first to enable directed troubleshooting for applications and microservices SAN MATEO, Calif., Nov. 15, 2018 (GLOBE NEWSWIRE) -- SignalFx, the leader in real-time cloud monitoring for infrastructure, microservices, and applications, today unveiled SignalFx Microservices APM™, the industry’s first real-time application performance monitoring solution designed to accelerate troubleshooting for DevOps teams through advanced real-time analytics. Powered by NoSample™ distributed tracing architecture, SignalFx Microservices APM observes every single transaction – not just a small random sample – and reports on every anomaly. With the new Outlier Analyzer™, the most challenging issues can now be pinpointed and resolved with a single click. SignalFx Microservices APM is built on top of SignalFx’s advanced streaming analytics platform for metrics which applies unsurpassed data science in real-time to identify the root cause of critical application problems. Integration with advanced automat

Minerva Neurosciences to Host Roluperidone Update and Key Opinion Leader Discussion of Negative Symptoms in CNS/Psychiatric Diseases on November 20, 201815.11.2018 14:30Pressemelding

Minerva management to provide update on Phase 3 clinical trial with roluperidone and single-dose escalation study findings Additional topics to include review of recent BDNF data with roluperidone and KOL discussion of trans-diagnostic approach to treating negative symptoms in CNS/psychiatry diseases WALTHAM, Mass., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it will host a roluperidone update and key opinion leader event on Tuesday, November 20, 2018 beginning at 8:00 a.m. Eastern Time in New York. Members of Minerva’s senior management will be joined by an expert key opinion leader. Discussions will feature the following speakers and topics: Gregory P. Strauss, Ph.D., Assistant Professor; Director: Clinical Affective Neuroscience Laboratory; Director: Georgia Psychiatric Risk Evaluation Program; Depa

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom